Explore the latest news, stories, and groundbreaking research happening at the Institute of Biomedical Engineering. Stay updated on innovative projects, impactful discoveries, and the achievements of our talented students, faculty, and alumni shaping the future of biomedical science and engineering.
Professor Milica Radisic (BME, ChemE) has been awarded the 2023 Humboldt Research Award from the Alexander von Humboldt Foundation.
U of T Engineering has partnered with CCRM, BioZone and the School of Continuing Studies on a new set of microcredentials that will help workers across Canada’s biomanufacturing industry to upgrade or strengthen their skills.
New innovations in the ways that human cells are grown in laboratories could help speed up the development of cellular therapy, a branch of regenerative medicine that targets diseases that are incurable today. According to Professor Julie Audet (BME), some of the most significant challenges to achieving this goal have to do with how the therapeutic cells are produced.
Researchers at the University of Toronto and the Ted Rogers Centre for Heart Research have identified a previously unknown mechanism that governs the movement of cardiac progenitors during heart development in fruit fly embryos. By using advanced imaging techniques, mathematical modelling and genetic and biophysical manipulations, Dr. Rodrigo Fernandez-Gonzalez and colleagues shed light on the formation of the early heart tube and provide insights into the cellular causes of congenital heart defects.
Researchers at the University of Toronto have made progress in understanding the intricate cellular processes involved in tissue development and repair. The findings, published in the journal Current Biology, shed light on the mechanisms underlying collective cell migration, a fundamental behavior that plays a crucial role in both normal embryo development and pathological conditions such as cancer metastasis.
A study from U of T Engineering researchers shows that mechanical deformation of medically implantable materials — such as bending or twisting — can have a big impact on the formation of potentially harmful biofilms.
An MIT alumni profile on Dr. Michael Sefton and his research on regenerating organs to treat diabetes.
A study conducted by Tohoku University in collaboration with the University of Toronto and NTT Communication Science Laboratories has shown that applying substances to fingertips can considerably change the handling of a baseball. This finding, published in Communications Materials, could alter how these substances will be used in competitive baseball leagues.
A team of U of T Engineering researchers, led by Professor Omar F. Khan (BME), has partnered with biotechnology company Moderna to develop next-generation RNA platform technologies.
Microscopes are some of the most powerful tools in cell biology — but what if the cell component that needs to be imaged is smaller than the wavelengths of visible light? A new study from Professor Chris Yip (ChemE, BME) proposes a solution, one that could help advance research into cancer and other diseases.
A research team from U of T Engineering has discovered previously unknown phenomena in the growth of nanoparticles. The insights could open new ways of engineering these tiny structures for a variety of purposes, from designing next-generation solar cells to developing new medical tests and treatments.
The Centre for Research and Applications in Fluidic Technologies (CRAFT) has opened a new and expanded Tissue Foundry at the University of Toronto. The new facility builds CRAFT’s fabrication capacity following the launch of its Device Foundry in 2021.
The Donnelly Centre is swelling its ranks of leading researchers with two new faculty appointments.
Dr. Omar Khan is one of four researchers are the latest to receive support to spin-off aspects of their Medicine by Design-funded research into an early-stage product or venture as part of Medicine by Design’s Pivotal Experiment Fund, which has distributed more than $2.5-million in funding since its launch in early 2021.
A U of T Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.
A team of U of T Engineering researchers, led by Professor Molly Shoichet (ChemE, BME, Donnelly), has designed a new way to grow cells in a laboratory that enables them to better emulate cancerous tumours.
U of T Engineering researchers have grown a small-scale model of a human left heart ventricle in the lab. The bioartificial tissue construct is made with living heart cells and beats strongly enough to pump fluid inside a bioreactor.